IRhythm Technologies PE Ratio 2015-2025 | IRTC
Current and historical p/e ratio for IRhythm Technologies (IRTC) from 2015 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. IRhythm Technologies PE ratio as of July 30, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| IRhythm Technologies PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-31 | 140.18 | 0.00 | |
| 2025-03-31 | 104.68 | $-3.14 | 0.00 |
| 2024-12-31 | 90.17 | $-3.64 | 0.00 |
| 2024-09-30 | 74.24 | $-4.86 | 0.00 |
| 2024-06-30 | 107.64 | $-4.27 | 0.00 |
| 2024-03-31 | 116.00 | $-4.23 | 0.00 |
| 2023-12-31 | 107.04 | $-4.05 | 0.00 |
| 2023-09-30 | 94.26 | $-3.46 | 0.00 |
| 2023-06-30 | 104.32 | $-3.28 | 0.00 |
| 2023-03-31 | 124.03 | $-3.47 | 0.00 |
| 2022-12-31 | 93.67 | $-3.89 | 0.00 |
| 2022-09-30 | 125.28 | $-4.32 | 0.00 |
| 2022-06-30 | 108.03 | $-4.42 | 0.00 |
| 2022-03-31 | 157.47 | $-4.21 | 0.00 |
| 2021-12-31 | 117.69 | $-3.45 | 0.00 |
| 2021-09-30 | 58.56 | $-2.68 | 0.00 |
| 2021-06-30 | 66.35 | $-2.04 | 0.00 |
| 2021-03-31 | 138.86 | $-2.20 | 0.00 |
| 2020-12-31 | 237.21 | $-1.59 | 0.00 |
| 2020-09-30 | 238.11 | $-1.91 | 0.00 |
| 2020-06-30 | 115.89 | $-2.48 | 0.00 |
| 2020-03-31 | 81.35 | $-2.19 | 0.00 |
| 2019-12-31 | 68.09 | $-2.18 | 0.00 |
| 2019-09-30 | 74.11 | $-2.14 | 0.00 |
| 2019-06-30 | 79.08 | $-1.83 | 0.00 |
| 2019-03-31 | 74.96 | $-1.88 | 0.00 |
| 2018-12-31 | 69.48 | $-2.02 | 0.00 |
| 2018-09-30 | 94.66 | $-1.89 | 0.00 |
| 2018-06-30 | 81.13 | $-1.75 | 0.00 |
| 2018-03-31 | 62.95 | $-1.53 | 0.00 |
| 2017-12-31 | 56.05 | $-1.30 | 0.00 |
| 2017-09-30 | 51.88 | $-1.19 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $4.472B | $0.592B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.883B | 59.65 |
| Hims & Hers Health (HIMS) | United States | $14.668B | 152.40 |
| Doximity (DOCS) | United States | $11.054B | 51.17 |
| Tempus AI (TEM) | United States | $10.008B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.870B | 60.47 |
| Hinge Health (HNGE) | United States | $3.513B | 0.00 |
| Privia Health (PRVA) | United States | $2.388B | 163.25 |
| 10x Genomics (TXG) | United States | $1.713B | 0.00 |
| Phreesia (PHR) | United States | $1.608B | 0.00 |
| Enovis (ENOV) | United States | $1.544B | 8.61 |
| Azenta (AZTA) | United States | $1.530B | 71.11 |
| Schrodinger (SDGR) | United States | $1.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.476B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 24.55 |
| Evolent Health (EVH) | United States | $1.162B | 99.00 |
| Claritev (CTEV) | United States | $0.636B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.532B | 0.00 |
| Standard BioTools (LAB) | United States | $0.524B | 0.00 |
| Veradigm (MDRX) | United States | $0.507B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.448B | 0.00 |
| Talkspace (TALK) | United States | $0.418B | 125.00 |
| TruBridge (TBRG) | United States | $0.315B | 698.67 |
| Outset Medical (OM) | United States | $0.300B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
| CapsoVision (CV) | United States | $0.190B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.175B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.077B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |